Improvement of standard treatment and survival on 1870 NSCLC patients by follow-up of CYFRA 21-1 level for 60 months (CROSBI ID 573159)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Pavićević, Radomir ; Bubanović, Gordana ; Krajna, Ana
engleski
Improvement of standard treatment and survival on 1870 NSCLC patients by follow-up of CYFRA 21-1 level for 60 months
RATIONALE:Tumor marker CYFRA 21-1 has been included in clinical practice as standard clinical method after research on all parameters that could influence its value and dynamics on 1036 samples.METHODS:The sample includes 1780 surgically treated patients by pneumonectomy (31%) or lobectomy (69%) in the period from 1997 and 1999 in hospital Jordanovac (56, 38% squamous cell carcinoma, 38, 64% adenocarcinoma and 4, 97% large cell carcinoma).CYFRA 21-1 level has been measured by ECLIA (Roche …
CYFRA 21-1; lung cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
A914-A914.
2003.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
American journal of respiratory and critical care medicine
New York (NY): American Thoracic Society (ATS)
1073-449X
Podaci o skupu
International Conference of American Thoracic Society
poster
16.05.2003-21.05.2003
Seattle (WA), Sjedinjene Američke Države
Povezanost rada
Kliničke medicinske znanosti
